STOCK TITAN

Nasdaq delisting pushes Zentek (Nasdaq: ZTEK) to OTC trading

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Zentek Ltd. (ZTEK) reports that its common shares will transition from trading on the Nasdaq Capital Market to the OTC Markets Group on September 2, 2026, after receiving a Nasdaq notice of delisting for non-compliance with the minimum bid price requirement. Zentek plans to request a hearing to appeal the delisting determination, but the hearing will not stay the suspension of trading, and Nasdaq trading is expected to be suspended at the open on that date. The company’s common shares will continue to trade on the TSX Venture Exchange under the symbol ZEN, which remains its primary listing. Zentek has applied for its shares to be quoted on the OTCQX Best Market and states that the transition to the OTC Markets Group is not expected to result in material impacts to its business or operations.

Positive

  • TSX Venture Exchange listing remains primary and unaffected, ensuring continued exchange trading for Zentek shares under symbol ZEN.
  • Zentek has applied for quotation on the OTCQX Best Market, the top tier of OTC Markets Group, which could help maintain liquidity and visibility after Nasdaq delisting.

Negative

  • Zentek received a Nasdaq notice that its shares will be delisted from the Nasdaq Capital Market due to non-compliance with the minimum bid price requirement.
  • Trading of Zentek’s common shares on Nasdaq is expected to be suspended at the open on September 2, 2026, with trading moving to the OTC Markets Group.
Commission File Number 001-41310 SEC registration reference for Zentek Ltd.
Nasdaq trading suspension date September 2, 2026 Date trading on the Nasdaq Capital Market is expected to be suspended at the open
Press release date August 28, 2026 Date Zentek announced the Nasdaq listing update
CEO contact telephone 437-826-3779 Telephone number provided for Mohammed (Moe) Jiwan, Chief Executive Officer
Nasdaq Capital Market market
"its common shares will transition from trading on The Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
minimum bid price requirement regulatory
"delisted from the Nasdaq Capital Market due to non-compliance with Nasdaq's minimum bid price requirement"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
OTC Markets Group market
"transition from trading on The Nasdaq Capital Market to the OTC Markets Group"
OTC Markets Group is a company that runs the trading platforms where shares of smaller or less-regulated companies are bought and sold outside major stock exchanges. For investors it matters because these platforms set disclosure and trading standards that affect how easy it is to buy or sell a stock and how much trustworthy information is available—think of it like a marketplace that organizes vendors by how transparent and reliable they are, which helps gauge risk and liquidity.
OTCQX Best Market market
"Zentek has applied to seek approval for its common shares to be quoted on the OTCQX Best Market"
OTCQX Best Market is the top tier of an over‑the‑counter (OTC) trading platform where companies voluntarily meet higher disclosure and governance standards than typical OTC listings. For investors, it signals relatively better transparency and oversight—think of it as a premium section of a flea market where sellers show more paperwork—yet these stocks still carry more liquidity and regulatory risk than listings on major national exchanges.
TSX Venture Exchange market
"The Company's common shares continue to trade on the TSX Venture Exchange under the symbol ZEN"
A junior stock exchange in Canada where smaller, early-stage companies list shares to raise capital and gain public visibility. Think of it as a farmers’ market for young businesses: it offers investors a chance to buy into fast-growing but higher-risk ventures, with looser listing rules and typically lower liquidity than major exchanges. It matters because performance and financing on this exchange can signal growth prospects or risk for investors.

FAQ

Why is Zentek Ltd. (ZTEK) being delisted from the Nasdaq Capital Market?

Zentek received a notice from Nasdaq that its common shares will be delisted from the Nasdaq Capital Market due to non-compliance with Nasdaq’s minimum bid price requirement.

When will Zentek (ZTEK) stop trading on Nasdaq and move to OTC Markets?

Trading of Zentek’s common shares on the Nasdaq Capital Market is expected to be suspended at the open on September 2, 2026, with shares transitioning to the OTC Markets Group on that date.

Will Zentek’s TSX Venture Exchange listing be affected by the Nasdaq delisting?

No. Zentek states that its common shares will continue to trade on the TSX Venture Exchange under the symbol ZEN and that this primary listing is unaffected by the Nasdaq determination.

Is Zentek (ZTEK) appealing the Nasdaq delisting decision?

Yes. Zentek intends to request a hearing from Nasdaq to appeal the delisting determination, although the company notes that the hearing will not stay the suspension of trading on Nasdaq.

On which OTC market tier does Zentek aim to trade after leaving Nasdaq?

Zentek has applied to seek approval for its common shares to be quoted on the OTCQX Best Market, described as the premier tier operated by the OTC Markets Group.

Does Zentek expect business impacts from moving off Nasdaq?

Zentek states that the transition of trading onto the OTC Markets Group is not expected to result in material impacts to its business or operations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2026

Commission File Number: 001-41310

ZENTEK LTD.

(Registrant)

1123 York Road

Guelph, Ontario N1E 6Z1 Canada

(Address of Principal Executive Offices)

Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☐            Form 40-F  ☒



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  ZENTEK LTD.
  (Registrant)
     
Date: August 28, 2026 By /s/ Wendy Ford
    Wendy Ford
    Chief Financial Officer


EXHIBIT INDEX

Exhibit Description of Exhibit
   
99.1 Press Release dated August 28, 2026 - Zentek Provides Update on Nasdaq Listing



Zentek Provides Update on Nasdaq Listing

Guelph, ON - August 28, 2026 - Zentek Ltd. (TSXV: ZEN) (Nasdaq: ZTEK) ("Zentek" or the "Company"), today announces that its common shares will transition from trading on The Nasdaq Capital Market to the OTC Markets Group on Tuesday, September 2, 2026. This transition follows the receipt by Zentek of a notice from The Nasdaq Stock Market LLC indicating that Zentek's common shares will be delisted from the Nasdaq Capital Market due to non-compliance with Nasdaq's minimum bid price requirement. Zentek intends to request a hearing from Nasdaq to appeal the delisting determination. The hearing will not stay the suspension of trading of Zentek's common shares, and trading of Zentek's common shares on The Nasdaq Capital Market is expected to be suspended at the open of trading on September 2, 2026.

The Company's common shares continue to trade on the TSX Venture Exchange under the symbol ZEN. The TSX Venture Exchange is the Company's primary listing and is unaffected by this determination. Shareholders are not required to take any action.

Zentek has applied to seek approval for its common shares to be quoted on the OTCQX Best Market, the premier tier operated by the OTC Markets Group.

The transition of trading onto the OTC Markets Group is not expected to result in material impacts to Zentek's business or operations.

Zentek will continue to provide updates on business progress and financial results in accordance with applicable Securities and Exchange Commission regulations. Additional information related to this announcement will be included in a Current Report on Form 8-K to be filed with the SEC.

About Zentek Ltd.

Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. Core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the Company's principal critical minerals asset.


For more information:

Mohammed (Moe) Jiwan

Chief Executive Officer, Zentek Ltd.

T: 437-826-3779

E: mjiwan2@zentek.com

www.zentek.com

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Filing Exhibits & Attachments

1 document